Cite
HARVARD Citation
Minagawa, T. et al. (2021). Impact of low‐dose tadalafil on adverse events after low‐dose‐rate brachytherapy for prostate cancer: A bi‐center randomized open‐label trial. International journal of urology. pp. 432-438. [Online].